C Pezzoli

558 total citations
18 papers, 447 citations indexed

About

C Pezzoli is a scholar working on Clinical Biochemistry, Biochemistry and Rheumatology. According to data from OpenAlex, C Pezzoli has authored 18 papers receiving a total of 447 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Clinical Biochemistry, 5 papers in Biochemistry and 4 papers in Rheumatology. Recurrent topics in C Pezzoli's work include Metabolism and Genetic Disorders (6 papers), Amino Acid Enzymes and Metabolism (4 papers) and Folate and B Vitamins Research (4 papers). C Pezzoli is often cited by papers focused on Metabolism and Genetic Disorders (6 papers), Amino Acid Enzymes and Metabolism (4 papers) and Folate and B Vitamins Research (4 papers). C Pezzoli collaborates with scholars based in Italy, Germany and United Kingdom. C Pezzoli's co-authors include Giorgio Stramentinoli, M. Galli-Kienle, G Curatola, Mauro Cimino, G. Vantini, Sergio Algeri, Erich Pfaff, Wilson J. Angerson, G Maresca and G. Bongartz and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Biochemical Pharmacology and Life Sciences.

In The Last Decade

C Pezzoli

18 papers receiving 427 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C Pezzoli Italy 9 108 95 80 74 70 18 447
M. P. Champion United Kingdom 14 299 2.8× 109 1.1× 78 1.0× 49 0.7× 20 0.3× 17 728
C. Plas France 14 243 2.3× 35 0.4× 50 0.6× 53 0.7× 21 0.3× 38 596
Raffaello Roesel United States 13 216 2.0× 45 0.5× 27 0.3× 27 0.4× 10 0.1× 43 527
Vincent Nuyens Belgium 12 161 1.5× 18 0.2× 51 0.6× 12 0.2× 40 0.6× 32 410
Hans‐Paul Juretschke Germany 14 197 1.8× 37 0.4× 50 0.6× 4 0.1× 28 0.4× 18 552
Hanspeter Egger Switzerland 10 39 0.4× 53 0.6× 213 2.7× 144 1.9× 9 0.1× 14 478
Libor Kozák Czechia 17 333 3.1× 78 0.8× 32 0.4× 8 0.1× 17 0.2× 37 769
Louie G. Linarelli United States 11 121 1.1× 20 0.2× 37 0.5× 26 0.4× 5 0.1× 20 438
Gemma Wallis United States 11 119 1.1× 29 0.3× 50 0.6× 15 0.2× 6 0.1× 12 410
Ann F.C. Roberts United Kingdom 8 105 1.0× 14 0.1× 21 0.3× 9 0.1× 17 0.2× 12 435

Countries citing papers authored by C Pezzoli

Since Specialization
Citations

This map shows the geographic impact of C Pezzoli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C Pezzoli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C Pezzoli more than expected).

Fields of papers citing papers by C Pezzoli

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C Pezzoli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C Pezzoli. The network helps show where C Pezzoli may publish in the future.

Co-authorship network of co-authors of C Pezzoli

This figure shows the co-authorship network connecting the top 25 collaborators of C Pezzoli. A scholar is included among the top collaborators of C Pezzoli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C Pezzoli. C Pezzoli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
2.
Droste, Dirk W., et al.. (2002). SonoVue<sup>®</sup> (BR1), a New Long-Acting Echocontrast Agent, Improves Transcranial Colour-Coded Duplex Ultrasonic Imaging. Cerebrovascular Diseases. 14(1). 27–32. 13 indexed citations
3.
Leen, Edward, Wilson J. Angerson, S. Yarmenitis, et al.. (2002). Multi-centre clinical study evaluating the efficacy of SonoVue™ (BR1), a new ultrasound contrast agent in Doppler investigation of focal hepatic lesions. European Journal of Radiology. 41(3). 200–206. 87 indexed citations
4.
Kaps, Manfred, D.A. Legemate, F. Ries, et al.. (2001). SonoVue™ in Transcranial Doppler Investigations of the Cerebral Arteries. Journal of Neuroimaging. 11(3). 261–267. 12 indexed citations
5.
Spinazzi, Alberto, et al.. (1996). Multicenter testing of gadobenate dimeglumine in magnetic resonance imaging of focal liver disease. Academic Radiology. 3. S415–S416. 5 indexed citations
6.
Pezzoli, C, M. Galli-Kienle, & Giorgio Stramentinoli. (1987). Lack of mutagenic activity of ademetionine in vitro and in vivo.. PubMed. 37(7). 826–9. 2 indexed citations
7.
Cimino, Mauro, G. Vantini, Sergio Algeri, et al.. (1984). Age-related modification of dopaminergic and β-adrenergic receptor system: Restoration to normal activity by modifying membrane fluidity with s-adenosylmethionine. Life Sciences. 34(21). 2029–2039. 112 indexed citations
8.
Pezzoli, C, M. Galli-Kienle, C. Di Padova, & Giorgio Stramentinoli. (1984). HPLC Method for the Evaluation of Blood Acetaldehyde without Ethanol Interference. Journal of Liquid Chromatography. 7(4). 765–778. 18 indexed citations
9.
Pezzoli, C, Rosamaria Fiorini, G Curatola, & Giorgio Stramentinoli. (1983). S-adenosylmethionine protects against erythrocyte membrane alterations induced in rabbits by cholesterol-rich diet. Pharmacological Research Communications. 15(9). 785–795. 7 indexed citations
10.
Pezzoli, C, et al.. (1982). Endometrial Pathological Changes after Fallopian Ring Tubal Ligation. Endoscopy. 14(4). 139–140. 4 indexed citations
11.
Stramentinoli, Giorgio, C Pezzoli, & M. Galli-Kienle. (1979). Protective role of S-adenosyl-l-methionine against acetaminophen induced mortality and hepatotoxicity in mice. Biochemical Pharmacology. 28(24). 3567–3571. 61 indexed citations
12.
Pezzoli, C, Giorgio Stramentinoli, M. Galli-Kienle, & Erich Pfaff. (1978). Uptake and metabolism of S-adenosyl-L-methionine by isolated rat hepatocytes. Biochemical and Biophysical Research Communications. 85(3). 1031–1038. 41 indexed citations
13.
Bartošek, I., A. Guaitani, Pia Villa, et al.. (1978). S-adenosyl-l-methionine: hepatic levels in rats during various stress situations. Biochemical Pharmacology. 27(22). 2649–2650. 7 indexed citations
14.
Placidi, Gian Franco, Giorgio Stramentinoli, C Pezzoli, & G.B. Cassano. (1978). A Study of the Distribution of Radioactive S-Adenosylmethionine in the Experimental Animal. PubMed. 18. 100–110. 3 indexed citations
15.
Stramentinoli, Giorgio, C Pezzoli, & M. Galli Kienle. (1978). Uptake of S-adenosyl-l-methionine by rabbit erythrocytes. Biochemical Pharmacology. 27(10). 1427–1430. 25 indexed citations
16.
Pezzoli, C, et al.. (1977). Distribution of S-adenosyl-L-(methyl-14C)methionine in animals.. PubMed. 27(9). 1680–4. 5 indexed citations
17.
Stramentinoli, Giorgio, et al.. (1975). [Pharmacological aspects of S-adenosyl-L-methionone in hepatology. (A) Biochemical signs. (B) Acute, chronic and fetal toxicity. (C) Biochemical and morphohistochemical changes in control rats and rats treated with S-adenosyl-L-methionine after experimental poisoning with various agents].. PubMed. 66(33). 1541–62. 3 indexed citations
18.
Stramentinoli, Giorgio, et al.. (1975). [Anti-inflammatory and analgesic action of S-adenosyl-L-methionine (SAMe) in experimental tests on laboratory animals].. PubMed. 66(83). 4434–42. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026